SB
PFE icon

SIG Brokerage’s Pfizer PFE Stock Holding History

SIG Brokerage’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.38M Buy
120,400
+80,400
+201% +$2.14M 0.09% 184
2025
Q4 		$996K Buy
40,000
+10,000
+33% +$252K 0.03% 364
2025
Q3 		$764K Buy
30,000
+18,600
+163% +$459K 0.02% 444
2025
Q2 		$276K Buy
+11,400
New +$266K 0.01% 572

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

SIG Brokerage's PFE Position: Q1 2026 in Review

SIG Brokerage reduced its Pfizer (PFE) stake by 8% in Q1 2026, selling an estimated $70.9K and leaving 30,686 shares worth $862K. The position accounts for 0.02% of the portfolio, ranked #446.

SIG Brokerage first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.42M in Q1 2025. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • SIG Brokerage held 30,686 shares of Pfizer worth $862K as of Q1 2026.
  • SIG Brokerage sold 2,664 Pfizer shares in Q1 2026, an estimated $70.9K.
  • Pfizer made up 0.02% of SIG Brokerage's portfolio in Q1 2026, its #446 holding.
  • SIG Brokerage first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • SIG Brokerage's Pfizer position peaked at $2.42M in Q1 2025.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on SIG Brokerage's 13F filing for Q1 2026, filed 15 May 2026.